O2 Consumption and Heart Rate Response to Battle Rope Exercise Protocol Versus UE Arm Bike Test in Adults With SCI
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03793595 |
Recruitment Status : Unknown
Verified April 2021 by Wayne Brewer, Texas Woman's University.
Recruitment status was: Recruiting
First Posted : January 4, 2019
Last Update Posted : April 19, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Spinal Cord Injury at T2 and Below | Device: Seated Battle Ropes Protocol Device: Seated Upper Extremity Arm Bike | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 20 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Oxygen Consumption and Heart Rate Response to Battle Rope Exercise Protocol Versus Upper Extremity Arm Bike Test in Adults With Spinal Cord Injury |
Actual Study Start Date : | March 20, 2019 |
Estimated Primary Completion Date : | January 2022 |
Estimated Study Completion Date : | January 2022 |

Arm | Intervention/treatment |
---|---|
Experimental: Seated Battle Ropes Protocol |
Device: Seated Battle Ropes Protocol
Participants will begin swinging the rope as previously described in the seated position using the double arm swing technique for 15 seconds at a cadence of 100 beats/ minutes with a 45 second rest break repeated 10 times. |
Active Comparator: Seated Upper Extremity Arm Bike |
Device: Seated Upper Extremity Arm Bike
A modified Young Men's Christian Association (YMCA) cycle test will be performed. |
- Cardiorespiratory fitness as assessed by maximum oxygen uptake (VO2max) [ Time Frame: about 10-15 minutes after start of the protocol ]VO2max will be measured using a portable metabolic cart (Cosmed k5b).
- Heart Rate [ Time Frame: about 10-15 minutes after start of the protocol ]
- Rate of perceived exertion as assessed by the Borg 6-20 Perceived exertion scale [ Time Frame: about 10-15 minutes after start of the protocol ]The Borg 6-20 Perceived exertion scale score ranges from 6-20, higher score indicates a worse outcome.
- Blood pressure [ Time Frame: about 10-15 minutes after start of the protocol ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Spinal cord lesion T2 or below
- Individuals with spinal cord injury for greater than six months
- Utilize manual wheelchair for greater than 10 hours a day
Exclusion Criteria:
- Current complaints of spinal, lower extremity or upper extremity pain or musculoskeletal disorder that prevents the subject from performing repetitive upper extremity cycling or grasping and swinging the weighted ropes against the floor
- A current diagnosis of a chronic or acute cardiovascular, metabolic, renal or pulmonary disease including use of a pacemaker
- Anyone currently taking beta blocker medication
- Anyone with blood pressure >140/90 at the time of testing or with in the 2 weeks prior to testing
- Diagnosed sickle cell disease or sickle cell trait
- Severe spasticity or joint contracture preventing subject from performing upper extremity cycling or swinging of weighted ropes
- Subjects with current decubital ulcers
- History of autonomic dysreflexia in the last 6 months
- Require physician follow-up prior to starting exercise based on PAR-Q+ questionnaire

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03793595
Contact: Wayne A Brewer, PhD | 713-794-2074 | wbrewer@twu.edu |
United States, Texas | |
Texas Woman's University | Recruiting |
Houston, Texas, United States, 77030 | |
Contact: Wayne A Brewer, PhD 713-794-2074 wbrewer@twu.edu | |
Principal Investigator: Wayne Brewer, PhD, MPH |
Principal Investigator: | Wayne A Brewer, PhD | Texas Woman's University |
Responsible Party: | Wayne Brewer, Associate Professor, Texas Woman's University |
ClinicalTrials.gov Identifier: | NCT03793595 |
Other Study ID Numbers: |
IRB-FY2019-34 |
First Posted: | January 4, 2019 Key Record Dates |
Last Update Posted: | April 19, 2021 |
Last Verified: | April 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | Yes |
Product Manufactured in and Exported from the U.S.: | No |
Spinal Cord Injuries Spinal Cord Diseases Central Nervous System Diseases |
Nervous System Diseases Trauma, Nervous System Wounds and Injuries |